Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease

American Journal of Pathology

Volumn 183, Issue 6, 2013, Pages 1826-1840

  Pienaar, Ilse S ^a   Elson, Joanna L ^b,c   Racca, Claudia ^d   Nelson, Glyn ^b   Turnbull, Douglass M ^b,e   Morris, Christopher M ^b,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NORTH WEST UNIVERSITY   (South Africa)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA SYNUCLEIN; CYCLOOXYGENASE 1; GLUTAMATE DECARBOXYLASE 65; GLYCINE RECEPTOR; MITOCHONDRIAL PROTEIN; PORIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

AGED; ARTICLE; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CELL SIZE; CELL STRUCTURE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CYTOPATHOLOGY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE CELL NECROSIS; NEUROPATHOLOGY; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POSTMORTEM CHANGE; PRIORITY JOURNAL; RESPIRATORY CHAIN; SOMATIC CELL; UPREGULATION;

AGED; AGED, 80 AND OVER; ANIMALS; CHOLINERGIC NEURONS; DISEASE MODELS, ANIMAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MICE; MITOCHONDRIA; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS;

EID: 84888222767     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.09.002     Document Type: Article

References (88)

1. J. Jankovic Parkinson's disease: clinical features and diagnosis J Neurol Neurosurg Psych 79 2008 368 376
2. D.W. Dickson, H. Braak, J.E. Duda, C. Duyckaerts, T. Gasser, G.M. Halliday, J. Hardy, J.B. Leverenz, K. Del Tredici, Z.K. Wszolek, and I. Litvan Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria Lancet Neurol 8 2009 1150 1157
3. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795
4. K.S. McNaught, P. Shashidharan, D.P. Perl, P. Jenner, and C.W. Oleo Aggresome related biogenesis of Lewy bodies Eur J Neurosci 16 2002 2136 2148
5. P.C. Keane, M. Kurzawa, P.G. Blain, and C.M. Morris Mitochondrial dysfunction in Parkinson's disease Parkinsons Dis 2011 2011 716871
6. A.H. Schapira, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269
7. R.H. Haas, F. Nasirian, K. Nakano, D. Ward, M. Pay, R. Hill, and C.W. Shults Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease Ann Neurol 37 1995 714 722
8. M. Gu, J.M. Cooper, J.W. Taanman, and A.H. Schapira Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease Ann Neurol 44 1998 177 186
9. A.M. Penn, T. Roberts, J. Hodder, P.S. Allen, G. Zhu, and W.R. Martin Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle Neurology 45 1995 2097 2099
10. D.J. Taylor, D. Krige, P.R. Barnes, G.J. Kemp, M.T. Carroll, V.M. Mann, J.M. Cooper, C.D. Marsden, and A.H. Schapira A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease J Neurol Sci 125 1994 77 81
11. A.H. Schapira Mitochondrial involvement in Parkinson's disease. Huntington's disease, hereditary spastic paraplegia and Friecheich's ataxia Biochim Biophys Acta 1410 1999 159 170
12. A. Panov, S. Dikalov, N. Shalbuyeva, G. Taylor, T. Sherer, and J.T. Greenamyre Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication J Biol Chem 280 2005 42026 42035
13. S. Przedborski, K. Tieu, C. Perier, and M. Vila MPTP as a mitochondrial neurotoxic model of Parkinson's disease J Bioenerg Biomembr 36 2004 375 379
14. D.P. Narendra, and R.J. Youle Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control Antioxid Redox Signal 14 2011 1929 1938
15. H. Braak, K. Del Tredici, U. Rüb, R.A.I. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211
16. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies Proc Natl Acad Sci U S A 95 1998 6469 6473
17. K.A. Jellinger Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts Mov Disord 27 2012 8 30
18. H.J. Kim Alpha-synuclein expression in patients with Parkinson's disease: a clinician's perspective Exp Neurobiol 22 2013 77 83
19. H. Braak, and E. Braak Pathoanatomy of Parkinson's disease J Neurol 247 2000 113-110
20. S. Datta, and D.F. Siwek Single cell activity patterns of pedunculopontine tegmentum neurons across the sleep-wake cycle in the freely moving rats J Neurosci Res 70 2002 611 621
21. A. Iranzo, J.L. Molinuevo, J. Santamaria, M. Serradell, M.J. Marti, F. Valldeoiola, and E. Tolosa Rapid-eye movement sleep behaviour disorder as an early marker for neurodegenerative disorder: a descriptive study Lancet Neurol 5 2006 572 577
22. A.R. Granata, and S.T. Kitai Inhibitory substantia nigra inputs to the pedunculopontine neurons Exp Brain Res 86 1991 459 466
23. L.N. Hazrati, and A. Parent Projection from the deep cerebellar nuclei to the pedunculopontine nucleus in the squirrel monkey Brain Res 585 1992 267 271
24. W.L. Inglis, and P. Winn The pedunculopontine tegmental nucleus: where the striatum meets the reticular formation Prog Neurobiol 47 1995 1 29
25. N. Jenkinson, D. Nandi, K. Muthusamy, N.J. Ray, R. Gregory, J.F. Stein, and T.Z. Aziz Anatomy, physiology and pathophysiology of the pedunculopontine nucleus Mov Disord 24 2009 319 328
26. B. Lavoie, and A. Parent Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra J Comp Neurol 344 1994 232 241
27. D.B. Rye, H.J. Lee, C.B. Saper, and B.H. Wainer Medullary and spinal efferents of the pedunculopontine tegmental nucleus and adjacent mesopontine tegmentum in the rat J Comp Neurol 269 1988 315 341
28. B.M. Spann, and I. Grofova Origin of ascending and spinal pathways from the nucleus tegmenti pedunculopontinus in the rat J Comp Neurol 283 1989 13 27
29. T.L. Steininger, D.B. Rye, and B.H. Wainer Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies J Comp Neurol 321 1992 515 543
30. P. Winn, V.J. Brown, and W.L. Inglis On the relationships between the striatum and the pedunculopontine tegmental nucleus Crit Rev Neurobiol 11 1997 241 261
31. E.C. Hirsch, A.M. Graybiel, C. Duyckaerts, and F. Javoy-Agid Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy Proc Natl Acad Sci U S A 84 1987 5976 5980
32. J.O. Rinne, S.Y. Ma, M.S. Lee, Y. Collan, and M. Röyttä Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients Parkinsonism Relat Disord 14 2008 553 557
33. L. Rochester, A.J. Yarnall, M.R. Baker, R.V. David, S. Lord, B. Galna, and D.J. Burn Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease Brain 135 2012 2779 2788
34. C. Karachi, D. Grabli, F.A. Bernard, D. Tandé, N. Wattiez, H. Belaid, E. Bardinet, A. Prigent, H.P. Nothacker, S. Hunot, A. Hartmann, S. Lehéricy, E.C. Hirsch, and C. François Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease J Clin Invest 120 2010 1026 1033
35. J. Kojima, Y. Yamaji, M. Matsumura, A. Nambu, M. Inase, H. Tokuno, M. Takada, and H. Imai Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey Neurosci Lett 226 1997 111 114
36. B.N. Dugger, M.E. Murray, B.F. Boeve, J.E. Parisi, E.E. Benarroch, T.J. Ferman, and D.W. Dickson Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to REM sleep behaviour disorder Neuropathol Appl Neurobiol 38 2012 142 152
37. P. Plaha, and S.S. Gill Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease Neuroreport 16 2005 1883 1887
38. A. Stefani, A.M. Lozano, A. Peppe, P. Stanzione, S. Galati, D. Tropepi, M. Pierantozzi, L. Brusa, E. Scarnati, and P. Mazzone Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease Brain 130 2007 1596 15607
39. N.Z. Lax, P.D. Hepplewhite, A.K. Reeve, V. Nesbitt, R. McFarland, E. Jaros, R.W. Taylor, and D.M. Turnbull Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study J Neuropathol Exp Neurol 71 2012 148 161
40. A.K. Reeve, T.K. Park, E. Jaros, G.R. Campbell, N.Z. Lax, P.D. Hepplewhite, K.J. Krishnan, J.L. Elson, C.M. Morris, I.G. McKeith, and D.M. Turnbull Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons Arch Neurol 69 2012 385 393
41. K. Mizukawa, P.L. McGeer, H. Tago, J.H. Peng, E.G. McGeer, and H. Kimura The cholinergic system of the human hindbrain studied by choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry Brain Res 379 1986 39 55
42. M. Alam, K. Schwabe, and J.K. Krauss The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation Brain 134 2010 11 23
43. S. Renshaw Immunohistochemistry: Methods Express 2007 Scion Publishing Ltd Cambridge 46
44. I.S. Pienaar, and W. Van de Berg A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats Exp Neurol 248 2013 213 223
45. C. Altar, J. Walter, A. Neve, and J.F. Marshall Computer-assisted video analysis of ['H]spiroperidol binding in autoradiographs J Neurosci Methods 10 1984 173 188
46. C. Porro, S. Fonda, P. Baraldi, G.P. Bird, and M. Cavazzuti Computer-assisted analyses of [I4C]2-DG autoradiographs employing a general purpose image processing system J Neurosci Methods 11 1984 243 250
47. E.M. Brey, Z. Lalani, C. Johnston, M. Wong, L.V. McIntyre, P.J. Duke, and C.W. Patrick Jr. Automated selection of DAB-labeled tissue for immunohistochemical quantification J Histochem Cytochem 51 2003 575 584
48. S. Leal, C. Diniz, C. Sá, J. Goncalves, A.S. Soares, C. Rocha-Pereira, and P. Fresco Semiautomated computer-assisted image analysis to quantify 3,3′-diaminobenzidine tetrahydrochloride-immunostained small tissues Anal Biochem 357 2006 137 143
49. S.C. Helps, E. Thornton, T.J. Kleinig, J. Manavis, and R. Vink Automatic non-subjective estimation of antigen content visualized by immunohistochemistry using color deconvolution Appl Immunohistochem Mol Morphol 20 2012 89 90
50. A. Bender, K.J. Krishnan, C.M. Morris, G.A. Taylor, A.K. Reeve, R.H. Perry, E. Jaros, J.S. Hersheson, J. Betts, T. Klopstock, R.W. Taylor, and D.M. Turnbull High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson's disease Nat Genet 38 2006 515 517
51. K.J. Krishnan, T.E. Ratnaike, H.L. De Gruyter, E. Jaros, and D.M. Turnbull Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer disease Neurobiol Aging 33 2012 2210 2214
52. I.S. Pienaar, D. Burn, C.M. Morris, and D. Dexter Synaptic protein alterations in Parkinson's disease Mol Neurobiol 45 2012 126 143
53. J.M. Baizabal, C. Valencia, G. Guerrero-Flores, and L. Covarrubias Telencephalic neural precursor cells show transient competence to interpret the dopaminergic niche of the embryonic midbrain Dev Biol 349 2011 192 203
54. I. Poyatos, J. Ponce, C. Aragón, C. Giménez, and F. Zafra The glycine transporter GLYT2 is a reliable marker for glycine-immunoreactive neurons Mol Brain Res 49 1997 63 70
55. J.Z. Li, M.P. Vawter, D.M. Walsh, H. Tomita, S.J. Evans, P.V. Choudary, J.F. Lopez, A. Avelar, V. Shokoohi, T. Chung, O. Mesarwi, E.G. Jones, S.J. Watson, H. Akil, W.E. Bunney Jr., and R.M. Myers Systematic changes in gene expression in post-mortem human brains associated with tissue pH and terminal medical conditions Hum Mol Genet 13 2004 609 616
56. P.J. Harrison, P.R. Heath, S.L. Eastwood, P.W. Burnet, B. McDonald, and R.C. Pearson The relative importance of premortem acidosis and post-mortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins Neurosci Lett 200 1995 151 154
57. P.F. Durrenberger, S. Fernando, S. Kashefi, I. Ferrer, J.J. Hauw, D. Seilhean, C. Smith, R. Walker, S. Al-Sarraj, C. Troakes, M. Palkovits, M. Kasztner, I. Huitinga, T. Arzberger, D.T. Dexter, H. Kretzschmar, and R. Reynolds Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study J Neuropathol Exp Neurol 69 2010 70 81
58. I. Ferrer, A. Martinez, S. Boluda, P. Parchi, and M. Barrachina Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies Cell Tissue Bank 9 2008 181 194
59. B. Ford, C.J. Holmes, L. Mainville, and B.E. Jones GABAergic neurons in the rat pontomesencephalic tegmentum: co-distribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus J Comp Neurol 363 1995 177 196
60. A. Charara, Y. Smith, and A. Parent Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: phaseolus vulgaris-leucoagglutinin anterograde labeling combined with post-embedding glutamate and GABA immunohistochemistry J Comp Neurol 364 1996 254 266
61. P. Fort, P.H. Luppi, and M. Jouver Glycine immunoreactive neurons in the cat brain stem reticular formation Neuroreport 4 1993 1123 1126
62. E.M. Mineff, A. Popratiloff, R. Romansky, V. Kazakos, V. Kaimaktschieff, K.G. Usunoff, W. Ovtscharoff, and E. Marani Evidence for a possible glycinergic inhibitory neurotransmission in the midbrain and rostral pons of the rat studied by gethyrin Arch Physiol Biochem 106 1998 210 220
63. M. Ye, A. Hayar, B. Strotman, and E. Garcia-Rill Cholinergic modulation of fast inhibitory and excitatory transmission to pedunculopontine thalamic projecting neurons J Neurophysiol 103 2010 2417 2432
64. K. Saitoh, S. Hattori, W.J. Song, T. Isa, and K. Takakusaki Nigral GABAergic inhibition upon cholinergic neurons in the rat pedunculopontine tegmental nucleus Eur J Neurosci 18 2003 879 886
65. W.P. Gai, G.M. Halliday, P.C. Blumbergs, L.B. Geffen, and W.W. Blessing Substance containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease Brain 114 1991 2253 2267
66. P.L. Brooks, and J.H. Peever Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavioral disorder in mice J Neurosci 31 2011 7111 7121
67. E.J. Olson, B.F. Boeve, and M.H. Solber Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases Brain 123 2000 331 339
68. C.H. Schenck, and M.W. Mahowald REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP Sleep 25 2002 120 138
69. D. Nandi, T.Z. Aziz, N. Giladi, J. Winter, and J.F. Stein Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus Brain 125 2002 2418 2430
70. E. Shink, M. Sidibé, and Y. Smith Efferent connections of the internal globus pallidus in the squirrel monkey: II. Topography and synaptic organization of pallidal efferents to the pedunculopontine nucleus J Comp Neurol 382 1997 348 363
71. J.W. Lynch Native glycine receptor subtypes and their physiological roles Neuropharmacology 56 2009 303 309
72. M.H. Chase Confirmation of the consensus that glycinergic postsynaptic inhibition is responsible for the atonia of REM sleep Sleep 31 2008 1487 1491
73. M. Krenzer, C. Anaclet, R. Vetrivelan, N. Wang, L. Vong, B.B. Lowell, P.M. Fuller, and J. Lu Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia PLoS One 6 2011 e24998
74. K. Takakusaki, K. Obara, T. Nozu, and T. Okumura Modulatory effects of the GABAergic basal ganglia neurons on the PPN and the muscle tone inhibitory system in cats Arch Ital Biol 149 2011 385 405
75. J.R. Clements, and S. Grant Glutamate-like immunoreactivity in neurons of the laterodorsal tegmental and pedunculopontine nuclei in the rat Neurosci Lett 120 1990 70 73
76. A. Parent, M. Parent, and A. Charara Glutamatergic inputs to midbrain dopaminergic neurons in primates Parkinsonism Relat Disord 5 1999 193 201
77. A. Ames, and F.B. Nesbett Pathophysiology of ischemic cell death: II. Changes in plasma membrane permeability and cell volume Stroke 14 1983 227 233
78. C.J. McBain, S.F. Traynelis, and R. Dingledine Regional variation of extracellular space in the hippocampus Science 249 1990 674 677
79. W.J. Hoogendijk, C.W. Pool, D. Troost, A. van Zwieten, and D.F. Swaab Image analyser-assisted morphometry of the locus coeruleus in Alzheimer disease, Parkinson's disease and amyotrophic lateral sclerosis Brain 118 1995 131 143
80. R.A. Menke, J. Scholz, K.L. Miller, S. Deoni, S. Jbabdi, P.M. Matthews, and M. Zarei MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study Neuroimage 47 2009 435 441
81. G.M. Halliday Thalamic changes in Parkinson's disease Parkinsonism Relat Disord 15 2009 S152 S155
82. A.S. Lim, E. Moro, A.M. Lozano, C. Hamani, J.O. Dostrovsky, W.D. Hutchison, A.E. Lang, R.A. Wennberg, and B.J. Murray Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons Ann Neurol 66 2009 110 114
83. N.Z. Lax, I.S. Pienaar, A.K. Reeve, P.D. Hepplewhite, E. Jaros, R.W. Taylor, R.N. Kalaria, and D.M. Turnbull Microangiopathy in the cerebellum of patients with mitochondrial DNA disease Brain 135 2012 1736 1750
84. J.L. Elson, D.C. Samuels, D.M. Turnbull, and P.F. Chinnery Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age Am J Hum Genet 68 2001 802 806
85. H.A. Tuppen, E.L. Blakely, D.M. Turnbull, and R.W. Taylor Mitochondrial DNA mutations and human disease Biochim Biophys Acta 1797 2010 113 128
86. Y. Kraytsberg, E. Kudryavtseva, A.C. McKee, C. Geula, N.W. Kowall, and K. Khrapko Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons Nat Genet 38 2006 518 520
87. M. Sciacco, and E. Bonilla Cytochemistry and immunocytochemistry of mitochondria in tissue sections Methods Enzymol 264 1996 509 521
88. E. Bua, J. Johnson, A. Herbst, B. Delong, D. McKenzie, S. Salamat, and J.M. Aiken Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers Am J Hum Genet 79 2006 469 480